HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2187834Generated: November 1, 2026
N-(2-((1-(4-chlorobenzyl)piperidin-4-yl)methylamino)-2-oxoethyl)-2-amino-5-(trifluoromethyl)benzamide → 4-[[N-(2-amino-5-trifluoromethylbenzoyl)glycyl]aminomethyl]piperidine
https://huagongshe.com/reaction/2187834
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | N-(2-((1-(4-chlorobenzyl)piperidin-4-yl)methylamino)-2-oxoethyl)-2-amino-5-(trifluoromethyl)benzamide | HCID 9934977 | — |
| Catalyst | Palladium hydroxide | HCID 9942167 | — |
| Solvent | Formic acid methanol | HCID 18963719 | — |
| Product | 4-[[N-(2-amino-5-trifluoromethylbenzoyl)glycyl]aminomethyl]piperidine | HCID 18426227 | 86% |
Reaction Steps
A suspension of 1-(4-chlorobenzyl)-4-[{(N-(2-amino-5-trifluoromethylbenzoyl)glycyl)amino}methyl]piperidine (447 mg, 0.93 mmol) and Pd(OH)2 (60 mg, 0.23 mmol) in 5% HCO2H/methanol (10 mL) was stirred at 50° C. for 14 h. The Pd catalyst was filtered off through Celite, and the filtrate was concentrated. To the residue was added 1 N aqueous NaOH solution (15 mL) and the mixture was extracted with ethyl acetate (30 mL×3). The combined extracts were dried over anhydrous sodium sulfate, filtered, and concentrated. Column chromatography (SiO2, AcOEt/MeOH/Et3N=70/25/5) gave 4-[{(N-(2-amino-5-trifluoromethylbenzoyl)glycyl)amino}methyl ]piperidine (284 mg, 86%): ESI/MS m/e 359.0 (M++H, Cl16H21F3N4O2).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06410566B1 |
|---|
| Source dataset | uspto-grants-2002_06 |
|---|
| ORD ID | ord-cb3c39a201ba45c08bf1b6afec5fef98 |
|---|
| Source note | uspto-grants-2002_06 |
|---|